CLINICAL TRIALS PROFILE FOR CARBACHOL

All Clinical Trials for Carbachol

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00357864 ↗	Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow	Completed	Danish Headache Center		2006-07-01	To investigate headache score and accompanying symptoms during and after infusion of carbachol.
NCT00564408 ↗	Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients	Completed	Danish Headache Center	N/A	2007-08-01	The purpose of this study is to test if carbachol infusion induces headache in migraine subjects as well as intra- and extra-cerebral vasodilatation.
NCT00861211 ↗	Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects	Completed	Icagen	Phase 2	2008-10-01	The purpose of the study is to determine whether senicapoc can decrease changes in FEV1 following allergen challenge in atopic allergic subjects.
NCT02807415 ↗	ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor	Completed	Heidelberg University		2016-06-01	The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions.
NCT02807415 ↗	ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor	Completed	University of Giessen		2016-06-01	The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions.
NCT02807415 ↗	ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor	Completed	Hannover Medical School		2016-06-01	The academic investigator - initiated trial will evaluate in a postapproval setting whether, and if yes, to what extent and variability, the treatment with lumacaftor in combination with ivacaftor reverses the p.Phe508del CFTR - mediated basic defect in p.Phe508del homozygous subjects with cystic fibrosis under real life conditions.

Clinical Trial Conditions for Carbachol

Condition Name

Condition Name for Carbachol
Intervention	Trials
Presbyopia	3
Headache	2
Atopic Asthma	1
Cystic Fibrosis	1

Condition MeSH

Condition MeSH for Carbachol
Intervention	Trials
Presbyopia	3
Headache	2
Fibrosis	1
Cystic Fibrosis	1

Clinical Trial Locations for Carbachol

Trials by Country

Trials by Country for Carbachol
Location	Trials
Denmark	2
United States	2
United Kingdom	1
Germany	1

Trials by US State

Trials by US State for Carbachol
Location	Trials
Tennessee	1
California	1

Clinical Trial Progress for Carbachol

Clinical Trial Phase

Clinical Trial Phase for Carbachol
Clinical Trial Phase	Trials
Phase 3	2
Phase 2	2
N/A	1

Clinical Trial Status

Clinical Trial Status for Carbachol
Clinical Trial Phase	Trials
Completed	5
Not yet recruiting	2

Clinical Trial Sponsors for Carbachol

Sponsor Name

Sponsor Name for Carbachol
Sponsor	Trials
Visus Therapeutics	3
Danish Headache Center	2
Icagen	1

Sponsor Type

Sponsor Type for Carbachol
Sponsor	Trials
Other	8
Industry	1